Oscar Health, Inc. (OSCR) Q4 2024 Earnings Call Transcript
Portfolio Pulse from
Oscar Health, Inc. (OSCR) held its Q4 2024 earnings call on February 4, 2025. Key participants included CEO Mark Bertolini and CFO Scott Blackley. The call featured questions from analysts at Wells Fargo, Nephron Research, Baird, UBS, Piper Sandler, and Bank of America.
February 05, 2025 | 1:30 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oscar Health, Inc. conducted its Q4 2024 earnings call, providing insights into its financial performance and future outlook. The presence of top executives and analysts from major financial institutions indicates the importance of this event.
The earnings call is a routine event where Oscar Health's executives discuss financial results and outlook. The presence of analysts from major firms suggests significant interest, but without specific financial results or guidance, the immediate impact on stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100